Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medifast Inc (MED)

Medifast Inc (MED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,504,025
  • Shares Outstanding, K 11,898
  • Annual Sales, $ 501,000 K
  • Annual Income, $ 55,790 K
  • 60-Month Beta 0.81
  • Price/Sales 3.04
  • Price/Cash Flow 25.20
  • Price/Book 12.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.70
  • Number of Estimates 1
  • High Estimate 1.70
  • Low Estimate 1.70
  • Prior Year 1.16
  • Growth Rate Est. (year over year) +46.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.94 +0.46%
on 06/25/19
142.97 -11.51%
on 06/10/19
-11.91 (-8.60%)
since 05/24/19
3-Month
125.94 +0.46%
on 06/25/19
159.41 -20.63%
on 05/02/19
-5.90 (-4.46%)
since 03/26/19
52-Week
106.31 +19.01%
on 01/08/19
260.98 -51.52%
on 09/13/18
-33.69 (-21.03%)
since 06/26/18

Most Recent Stories

More News
Two Food Stocks to Buy After General Mills (GIS) Posts Weak Q4 Sales

General Mills (GIS) reported their fourth quarter earnings today before the opening bell.

GIS : 51.31 (-4.45%)
CHEF : 33.30 (+0.12%)
MED : 126.52 (+0.09%)
Archer Daniels Down 12% in a Year: Can Efforts Revive Stock?

Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.

PG : 109.73 (-1.78%)
CHEF : 33.30 (+0.12%)
ADM : 40.50 (+0.20%)
MED : 126.52 (+0.09%)
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR

Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR

SCVL : 26.44 (+0.23%)
MPX : 15.59 (-5.29%)
AMED : 118.70 (-2.31%)
NVR : 3,236.74 (-1.07%)
MED : 126.52 (+0.09%)
Avon Teams Up With HCL Technologies to Boost Digital Growth

Avon (AVP) partners with HCL Technologies to support the digital transformation of its business.

EL : 182.50 (-0.79%)
HELE : 131.33 (-1.14%)
AVP : 3.83 (-0.26%)
MED : 126.52 (+0.09%)
Consumer Beauty Hurts Coty: Can Efforts Revive Lost Sheen?

Coty's (COTY) Consumer Beauty unit struggles against soft organic sales. Also, supply-chain disruptions are a drag.

GIS : 51.31 (-4.45%)
CHEF : 33.30 (+0.12%)
MED : 126.52 (+0.09%)
COTY : 13.12 (-0.53%)
Newell to Sell USPC Business, Transformation Plan on Track

Newell (NWL) agrees to divest the United States Playing Card Company to Cartamundi Group. This move is in sync with the company's Transformation Plan.

CELH : 3.95 (+4.77%)
NWL : 15.38 (+3.57%)
CHEF : 33.30 (+0.12%)
MED : 126.52 (+0.09%)
Smucker's (SJM) Q4 Earnings Top Estimates, Buyout Boosts Sales

Smucker's (SJM) top and bottom lines improve during Q4. Performance gains from the Ainsworth buyout, while the divestiture of the U.S. baking business is a drag.

GIS : 51.31 (-4.45%)
SJM : 116.00 (-3.79%)
CHEF : 33.30 (+0.12%)
MED : 126.52 (+0.09%)
Will Archer Daniels' Strategic Growth Efforts Drive Stock?

Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.

CHEF : 33.30 (+0.12%)
CL : 72.35 (-2.11%)
ADM : 40.50 (+0.20%)
MED : 126.52 (+0.09%)
3 Reasons Why Medifast (MED) Is a Great Growth Stock

Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

MED : 126.52 (+0.09%)
Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike

Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.

UL : 61.76 (-1.15%)
MED : 126.52 (+0.09%)
CLX : 151.65 (-2.64%)
CHD : 72.72 (-3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade MED with:

Business Summary

Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, distributes, and sells weight loss and other health-related products through websites, multi-level marketing, telemarketing,...

See More

Key Turning Points

2nd Resistance Point 129.93
1st Resistance Point 128.22
Last Price 126.52
1st Support Level 125.58
2nd Support Level 124.65

See More

52-Week High 260.98
Fibonacci 61.8% 201.90
Fibonacci 50% 183.65
Fibonacci 38.2% 165.39
Last Price 126.52
52-Week Low 106.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar